0001171843-17-005763.txt : 20170928
0001171843-17-005763.hdr.sgml : 20170928
20170928113047
ACCESSION NUMBER: 0001171843-17-005763
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170926
FILED AS OF DATE: 20170928
DATE AS OF CHANGE: 20170928
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: MORRISON RICHARD G
CENTRAL INDEX KEY: 0001222906
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-35443
FILM NUMBER: 171106305
MAIL ADDRESS:
STREET 1: 1715 VERRAZZANO DRIVE
CITY: WILMINGTON
STATE: NC
ZIP: 28405
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ARGOS THERAPEUTICS INC
CENTRAL INDEX KEY: 0001105533
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 562110007
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
BUSINESS PHONE: 9192876300
MAIL ADDRESS:
STREET 1: 4233 TECHNOLOGY DR
CITY: DURHAM
STATE: NC
ZIP: 27704
FORMER COMPANY:
FORMER CONFORMED NAME: MERIX BIOSCIENCE INC
DATE OF NAME CHANGE: 20000207
4
1
formfour.xml
OWNERSHIP DOCUMENT
X0306
4
2017-09-26
0
0001105533
ARGOS THERAPEUTICS INC
ARGS
0001222906
MORRISON RICHARD G
C/O ARGOS THERAPEUTICS, INC.
4233 TECHNOLOGY DRIVE
DURHAM
NC
27704
1
0
0
0
Stock Option (right to buy)
0.17
2017-09-26
4
A
0
30000
0
A
2027-09-26
Common Stock
30000
30000
D
This option was granted on September 26, 2017 and vest in equal amounts quarterly over the next three years.
/s/ Lori R. Harrelson, attorney-in-fact
2017-09-28